Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue

Expert insights: Adapting treatment during the COVID-19 pandemic

Date

14 Sep 2020

Session

Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue

Presenters

Pippa Corrie

Authors

J. Larkin1, P.A. Ascierto2, P. Corrie3

Author affiliations

  • 1 Medicine Department, The Royal Marsden Hospital - NHS Foundation Trust, SW3 6JJ - London/GB
  • 2 Melanoma, Cancer Immunotherapy & Developmental Therapeutics, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, 80131 - Napoli/IT
  • 3 Department Of Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ - Cambridge/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and Introduction

Presenter: James Larkin

Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue

Resources:

Webcast

Summary and close

Presenter: James Larkin

Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.